-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX THERAPEUTICS shares rose 23% to break through $2 in after-hours trading after the company updated the progress of a clinical trial application for gout treatment submitted to Health Canada.

Zhitongcaijing·10/08/2026 20:17:30
Listen to the news
XORTX THERAPEUTICS shares rose 23% to break through $2 in after-hours trading after the company updated the progress of a clinical trial application for gout treatment submitted to Health Canada.